I laud the Morrison et al1 study describing acute hypertriglyceridemia in patients presenting with severe coronavirus disease 2019 (COVID-19) and being treated with tocilizumab (TCZ) as a treatment option. This… Click to show full abstract
I laud the Morrison et al1 study describing acute hypertriglyceridemia in patients presenting with severe coronavirus disease 2019 (COVID-19) and being treated with tocilizumab (TCZ) as a treatment option. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.